Unfractionated heparin is the treatment of choice for thrombotic diseases. It has a significant anticoagulant effect that should be monitored regularly to limit the risks of major blood loss, as well as recurrence of arterial and venous thrombi. There is already an alert tool from the laboratory that can be paired with a scientifically confirmed nomogram, allowing the necessary dose of heparin to be calculated according to the patient’s metabolic characteristics for greater efficacy.
This pilot project entails integrating a heparin nomogram into the computerized prescription system to assist prescribing and ensure the regular monitoring of heparin. The new tool should revise the current alert system to make it more efficient and better suited to the critical nature of the data being transmitted. It limits the risks of serious adverse events. This project could become a foundation for developments with the same alert efficiency for other medications.
Dr. Katherine Blondon, Deputy Head Physician, Directorate of Medicine and Quality, Geneva University Hospitals